License & Collaborate across TACs & glues to expand the druggable target universe

May 19-20, Boston MA

Accelerate licensing and collaboration deals across TAC and Molecular Glue discovery platforms and pipelines to validate capabilities, improve tissue specificity of protein homeostasis, and leverage known, undruggable targets across diseases.

CONFIRMED TO ATTEND

Why TPD & Induced Proximity Pharma Partnering Summit?

The TPD & Induced Proximity Pharma Partnering Summit is the premier business development forum for companies developing protein degradation TACs & Glues, and induced proximity-led protein enhancement, stabilization, or inhibition.

This exclusive summit brings together over 80 on-scope and in-strategy companies, providing unparalleled networking opportunities to connect with key decision-makers from leading pharma companies.

Designed to maximize your success, the scientifically focused environment of the summit guarantees a minimum of 25% meeting acceptance rates and at least four productive meetings with strong follow-up potential. Increase your meeting success rates and build meaningful collaborations in this exclusive setting.

Key Figures from Partnering Series

210+

meetings through the partnering portal

25%

acceptance rate of meetings, versus 11% industry standard

100+

total attendees, including: 20+ pharma, 65+ biotech

85+

companies

94%

director level and above

Size of Networking Opportunity

Total Audience Networking

Creating Alignment Through Targeted Critical Mass:

Exclusive to the targeted protein degradation and induced proximity pharma, biotech, and investor community, you are guaranteed a greater number of strategically matched interactions when networking candidly. Free from CROs/CDMOs or other service providers, maximize speaking with the highest priority contacts for your company while they and you are free from conflicting priorities.

Interested Group Matchmaking

Group Matchmaking

Tell us which pharma you want to meet in advance, and we will coordinate face-to-face, sit-down meetings with them during protected networking time at the pharma matchmaking tables on day one.

Individual Meetings: One-on-One Partneringâ„¢

The industry's favorite partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.

EXPERT SPEAKERS INCLUDE

Adam Gilbert, Executive Director, External Innovation Accelerator, Pfizer

Adam Gilbert

Executive Director, External Innovation Accelerator

Pfizer

Elena Diez, Senior Director External Innovation, Janssen

Elena Diez

Senior Director External Innovation

Janssen 

Yue Xiong, Chief Scientific Officer, Cullgen

Yue Xiong

Chief Scientific Officer

Cullgen

Randolph Lopez, Chief Technology Officer & Co-Founder, A-Alpha Bio

Randolph Lopez

Chief Technology Officer & Co-Founder

A-Alpha Bio

Steve Bellon, Chief Scientific Officer, Foghorn Therapeutics

Steve Bellon

Chief Scientific Officer

Foghorn Therapeutics

OTHER HANSON WADE SUMMITS